LU92135I9 - - Google Patents

Info

Publication number
LU92135I9
LU92135I9 LU92135C LU92135C LU92135I9 LU 92135 I9 LU92135 I9 LU 92135I9 LU 92135 C LU92135 C LU 92135C LU 92135 C LU92135 C LU 92135C LU 92135 I9 LU92135 I9 LU 92135I9
Authority
LU
Luxembourg
Prior art keywords
canine
caused
leptospira
methods
vaccines
Prior art date
Application number
LU92135C
Other languages
English (en)
Other versions
LU92135I2 (fr
Inventor
Joseph C/O Pfizer Inc Frantz
Thomas Jack C/O Pfizer Inc Newby
Cassius Mcallister C/O Pfizer Global R&D Tucker
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35657262&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92135(I9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of LU92135I2 publication Critical patent/LU92135I2/fr
Publication of LU92135I9 publication Critical patent/LU92135I9/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
LU92135C 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa LU92135I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/959,757 US20050089533A1 (en) 2003-01-29 2004-10-06 Canine vaccines against Bordetella bronchiseptica

Publications (2)

Publication Number Publication Date
LU92135I2 LU92135I2 (fr) 2013-03-18
LU92135I9 true LU92135I9 (fr) 2019-01-04

Family

ID=35657262

Family Applications (2)

Application Number Title Priority Date Filing Date
LU92136C LU92136I2 (fr) 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe Australis sérovar Bratislava
LU92135C LU92135I2 (fr) 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe canicola L.interrogans sérogroupe Icterohaemorrhagiae L.interrogans sérogroupe Australis sérovar Bratislava et L.kirschneri sérogroupe Grippotyphosa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU92136C LU92136I2 (fr) 2004-10-06 2013-01-16 Vaccin comprenant les souches inactivées de Leptospira en particulier L.interrogans sérogroupe Australis sérovar Bratislava

Country Status (26)

Country Link
US (2) US20050089533A1 (fr)
EP (1) EP1799253B1 (fr)
JP (2) JP4163245B2 (fr)
KR (3) KR101226869B1 (fr)
CN (2) CN101035558B (fr)
AT (1) ATE524193T1 (fr)
AU (1) AU2005290921C1 (fr)
BR (1) BRPI0516253A (fr)
CA (1) CA2583689C (fr)
CY (1) CY1114897T1 (fr)
DK (1) DK1799253T3 (fr)
ES (1) ES2370750T3 (fr)
HK (1) HK1112839A1 (fr)
LU (2) LU92136I2 (fr)
ME (1) ME01306B (fr)
MX (1) MX2007004133A (fr)
NO (1) NO20071385L (fr)
NZ (3) NZ576898A (fr)
PL (1) PL1799253T3 (fr)
PT (1) PT1799253E (fr)
RS (1) RS52035B (fr)
RU (1) RU2400248C2 (fr)
SI (1) SI1799253T1 (fr)
UA (1) UA91197C2 (fr)
WO (1) WO2006038115A1 (fr)
ZA (1) ZA200702166B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008032796A1 (fr) * 2006-09-13 2008-03-20 Nippon Zenyaku Kogyo Co., Ltd. Nouveau vaccin canin
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
KR20110126726A (ko) * 2005-10-07 2011-11-23 화이자 프로덕츠 인코포레이티드 개과 동물의 인플루엔자의 치료를 위한 백신 및 방법
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
EP2077856B1 (fr) * 2006-11-03 2015-08-12 Intervet International BV Vaccin contre la maladie de lyme canine
AU2015255165A1 (en) * 2006-12-27 2015-11-26 Zoetis Services Llc Methods of vaccine administration
EP3300743B1 (fr) * 2006-12-27 2023-06-14 Zoetis Services LLC Procédés d'administration de vaccin
EP2134742B1 (fr) 2007-02-27 2012-06-27 Wyeth LLC Compositions immunogènes de traitement et de prévention d'infections chez les animaux
US7878586B2 (en) * 2007-10-29 2011-02-01 The Boeing Company System and method for an anticipatory passenger cabin
NZ585877A (en) * 2007-12-21 2012-06-29 Pfizer Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
RU2565538C2 (ru) 2009-10-14 2015-10-20 Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити Выделение вируса, родственного парвовирусу-2 собак, от енота
EP2623118A4 (fr) 2010-09-28 2014-05-07 Kyoritsu Seiyaku Corp Composition d'adjuvant mucosal
AU2012213035A1 (en) * 2011-02-04 2013-08-15 Zoetis Services Llc Immunogenic Bordetella bronchiseptica compositions
RU2553222C2 (ru) * 2011-02-04 2015-06-10 ЗОИТИС ЭлЭлСи Композиции для лечения и предупреждения комплекса респираторных заболеваний собак
CN102343088B (zh) * 2011-10-14 2013-02-13 浙江诺倍威生物技术有限公司 一种犬传染性气管支气管炎二联活疫苗及其制备方法
EP2884996B1 (fr) * 2012-08-17 2020-01-08 Intervet International B.V. Composition immunogène de bactéries de leptospira mortes
US9480734B2 (en) 2012-08-17 2016-11-01 Intervet Inc. Immunogenic composition of killed leptospira bacteria
US9314519B2 (en) * 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
CZ307883B6 (cs) * 2013-01-29 2019-07-24 Bioveta, A.S. Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů
RU2546247C2 (ru) * 2013-06-06 2015-04-10 Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
KR101622554B1 (ko) 2014-07-16 2016-05-19 (주)양성그린바이오 면역항체를 이용한 강아지질병의 치료용 조성물의 제조방법
EP3909971A1 (fr) 2020-09-28 2021-11-17 Institute of Life Sciences (ILS) Vaccin de bétail à cellules entières pour maladies respiratoires
CN117187118A (zh) * 2023-08-16 2023-12-08 华中农业大学 一株支气管败血波氏杆菌a1218及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
JP2521226B2 (ja) * 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
WO1994022475A1 (fr) * 1993-03-31 1994-10-13 The Regents Of The University Of California PROTEINE CLONEE DE LA MEMBRANE EXTERIEURE DE LA $i(LEPTOSPIRA)
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
AUPO549497A0 (en) * 1997-03-07 1997-03-27 Agriculture Victoria Services Pty Ltd Novel bacterial pathogens
US6306623B1 (en) * 1998-02-24 2001-10-23 The University Of California Leptospiral major outer membrane protein LipL32
NZ501213A (en) * 1998-12-22 2001-09-28 Pfizer Prod Inc Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis
US20020058039A1 (en) * 2000-04-27 2002-05-16 Coyne Michael J. Method of measuring the duration of adequate immune memory in companion animals
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
WO2003098214A1 (fr) * 2002-05-17 2003-11-27 Fundação Oswaldo Cruz - FIOCRUZ Proteines avec domaines de repetition de bacterie, type ig (big), dans l'espece leptospira
KR20050062542A (ko) * 2002-08-26 2005-06-23 화이자 프로덕츠 인코포레이티드 소의 호흡기 및 생식기계 감염에 대한 백신
WO2004067031A1 (fr) * 2003-01-29 2004-08-12 Pfizer Products Inc. Vaccins canins contre la bordetella bronchiseptica
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
EP3300743B1 (fr) * 2006-12-27 2023-06-14 Zoetis Services LLC Procédés d'administration de vaccin

Also Published As

Publication number Publication date
ATE524193T1 (de) 2011-09-15
CA2583689C (fr) 2013-06-11
MX2007004133A (es) 2007-06-15
KR20120031294A (ko) 2012-04-02
EP1799253A1 (fr) 2007-06-27
NZ553867A (en) 2010-10-29
CY1114897T1 (el) 2016-12-14
CN101035558A (zh) 2007-09-12
NZ576898A (en) 2011-03-31
RU2400248C2 (ru) 2010-09-27
AU2005290921C1 (en) 2012-10-11
JP4163245B2 (ja) 2008-10-08
NO20071385L (no) 2007-04-18
JP2008515873A (ja) 2008-05-15
CN101035558B (zh) 2011-04-06
CN101791398A (zh) 2010-08-04
KR20070050499A (ko) 2007-05-15
BRPI0516253A (pt) 2008-08-26
WO2006038115A1 (fr) 2006-04-13
PT1799253E (pt) 2011-11-10
KR101226869B1 (ko) 2013-01-25
UA91197C2 (ru) 2010-07-12
EP1799253B1 (fr) 2011-09-14
LU92136I2 (fr) 2013-03-18
RS52035B (en) 2012-04-30
AU2005290921B2 (en) 2010-07-08
LU92136I9 (fr) 2019-01-04
CA2583689A1 (fr) 2006-04-13
ZA200702166B (en) 2008-11-26
ME01306B (me) 2013-12-20
KR20080096610A (ko) 2008-10-30
DK1799253T3 (da) 2011-11-28
NZ591422A (en) 2012-09-28
AU2005290921A1 (en) 2006-04-13
LU92135I2 (fr) 2013-03-18
JP2008239627A (ja) 2008-10-09
HK1112839A1 (en) 2008-09-19
PL1799253T3 (pl) 2012-01-31
US20050089533A1 (en) 2005-04-28
US20080175860A1 (en) 2008-07-24
RU2007112480A (ru) 2008-11-20
SI1799253T1 (sl) 2011-11-30
ES2370750T3 (es) 2011-12-22

Similar Documents

Publication Publication Date Title
LU92135I9 (fr)
TW200505476A (en) Canine vaccines against bordetella bronchiseptica
HRP20050192B1 (hr) Cjepivo za infekcije dišnog i spolnog sustava kod goveda
AR064530A1 (es) Procedimientos para la administracion de vacunas
IL131678A0 (en) An immunological composition comprising a borrelia burgdorferi antigen and its use
WO2004096993A3 (fr) Souches de metapneumovirus et leur utilisation dans des preparations de vaccin et en tant que vecteurs pour l'expression de sequences d'antigenes et procedes pour propager un virus
WO2004093904A3 (fr) Methodes pour prevenir les maladies genesiques des bovins
BRPI0407436A (pt) Composições adesivas para dentaduras, bem como método para a obtenção de efeito antiplaca
AR070675A1 (es) Bacterinas tratadas termicamente y vacunas de emulsion preparadas a partir de tales bacterinas tratadas termicamente
RU2009120894A (ru) Вакцина против лаймской болезни собак
WO2008106393A3 (fr) Compositions immunogènes et procédés de traitement et de prévention d'infections chez les animaux
TH71070A (th) วัคซีนสุนัขต้าน Bordetella bronchiseptica
AR045152A1 (es) Vacunas virales mutantes
TH94300A (th) องค์ประกอบก่อภูมิคุ้มกัน pcv2 ชนิดมัลติเวเลนต์ และวิธีของการผลิตองค์ประกอบเหล่านี้